{
    "clinical_study": {
        "@rank": "30013", 
        "arm_group": {
            "arm_group_label": "linseed oil", 
            "arm_group_type": "Active Comparator"
        }, 
        "brief_summary": {
            "textblock": "The study was performed to investigate the effects of a daily consumption of linseed oil on\n      fatty acid distribution in plasma and red blood cell lipids and blood lipids in vegetarians."
        }, 
        "brief_title": "Effects of Supplementation With Linseed Oil on Blood Lipids in Vegetarians", 
        "completion_date": {
            "#text": "December 2009", 
            "@type": "Actual"
        }, 
        "condition": "Inter-conversion n-3 PUFA, Vegetarians", 
        "detailed_description": {
            "textblock": "Recent studies suggest that the daily intake of n-3 LC-PUFA (EPA and DHA) can modulate\n      cardiovascular risk factors and prevent lifestyle diseases.\n\n      The major dietary source of EPA and DHA is seafood (seaweeds and fatty cold water fishes),\n      but they can also be found in lean red meat, in organ meats such as liver and brain.\n      Vegetarians who do not eat meat or fish, have very low or negligible intakes of EPA (< 5 mg\n      EPA/d) and DHA.\n\n      The purpose of the present study is to explore the tissue distribution and inter-conversion\n      of ALA to n-3 LC-PUFA as consequence of linseed oil supplementation in vegetarians.\n\n      Eight vegetarians (3 m; 5 f) who do not eat meat, fish or seaweeds such as algae foods since\n      least two years ago and two subjects (1 m; 1w) who consume the normal western style diet\n      living in Jena (Germany) entered the study. The participants consumed 10 mL linseed oil per\n      day for 10 weeks. The resulting daily dose of ALA was approx. 5.7 g/d."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  for the vegetarian sub-group : vegetarian diet pattern\n\n        Exclusion Criteria:\n\n          -  high performance sport, daily alcohol intake and the in-take of dietary supplements\n             (e.g., fish oil capsules)\n\n          -  for the vegetarian sub-group, the consumption of fish and algae products (e.g.\n             seaweeds, sushi)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "30 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01788917", 
            "org_study_id": "H39_09"
        }, 
        "intervention": {
            "arm_group_label": "linseed oil", 
            "description": "10 ml linseed oil per day over 10 weeks (without control oil)", 
            "intervention_name": "linseed oil", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "n-3 LC-PUFA, vegetarians, fatty acids, blood lipids", 
        "lastchanged_date": "February 7, 2013", 
        "number_of_arms": "1", 
        "official_title": "Effects of Supplementation With Linseed Oil on Blood Lipids and Fatty Acid Profile in Plasma and Erythrocyte Lipids in Vegetarians", 
        "other_outcome": {
            "description": "transferrin, ferritin, transferrin saturation, total ferritin", 
            "measure": "parameters of iron status", 
            "safety_issue": "No", 
            "time_frame": "10 weeks"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "German Federal Ministry of Education and Research: Germany", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "EPA concentrations in plasma lipids and red blood cell lipids", 
            "safety_issue": "No", 
            "time_frame": "10 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01788917"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Jena", 
            "investigator_full_name": "Gerhard Jahreis", 
            "investigator_title": "Professor Dr. G. Jahreis", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "total cholesterol, triacylglycerides, high density cholesterol, low density cholesterol, lipoprotein a", 
            "measure": "blood lipids", 
            "safety_issue": "No", 
            "time_frame": "10 weeks"
        }, 
        "source": "University of Jena", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Jena", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2009", 
        "study_design": "Endpoint Classification: Bio-availability Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}